A clinical conundrum: the detrimental effect of TNF antagonists in multiple sclerosis.

about

Multiple sclerosis-a quiet revolution

P2860

Q26826930-215A29D5-34E4-4952-BD1D-64538B566B1B

P2860

A clinical conundrum: the detrimental effect of TNF antagonists in multiple sclerosis.

Item

http://www.wikidata.org/entity/Q39352140

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

A clinical conundrum: the detrimental effect of TNF antagonists in multiple sclerosis.

@en

A clinical conundrum: the detrimental effect of TNF antagonists in multiple sclerosis.

@nl

type

Item

label

A clinical conundrum: the detrimental effect of TNF antagonists in multiple sclerosis.

@en

A clinical conundrum: the detrimental effect of TNF antagonists in multiple sclerosis.

@nl

prefLabel

A clinical conundrum: the detrimental effect of TNF antagonists in multiple sclerosis.

@en

A clinical conundrum: the detrimental effect of TNF antagonists in multiple sclerosis.

@nl

P1476

A clinical conundrum: the detrimental effect of TNF antagonists in multiple sclerosis.

@en

P2093

John I Bell

http://www.w3.org/2001/XMLSchema#string

Lars Fugger

http://www.w3.org/2001/XMLSchema#string

P2860

Multiple sclerosis in 2012: Novel therapeutic options and drug targets in MS

TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

The TNF and TNF receptor superfamilies: integrating mammalian biology

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

Multiple sclerosis

The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor

Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci

Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis?

The therapeutic potential of tumor necrosis factor for autoimmune disease: a mechanistically based hypothesis.

P304

1397-1404

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/PGS.13.140

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Calliope A. Dendrou

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24024893

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis

A clinical conundrum: the detrimental effect of TNF antagonists in multiple sclerosis.

about

P2860

P2860

A clinical conundrum: the detrimental effect of TNF antagonists in multiple sclerosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921